FDA to Review Post-Market Safety Checks
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration will ask the Institute of Medicine to study the  agency's safety monitoring of medicines already on the market,  Acting FDA Commissioner Lester Crawford said on Friday.
WASHINGTON Congressional critics of two big federal mortgage programs say they&#39;ll renew efforts to clamp tighter regulatory controls on Fannie Mae and Freddie Mac.